Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Asia Pacific | 2022

Procedure deferrals due to the COVID-19 pandemic severely impacted the Asia Pacific GI endoscopy device market, and the elective nature of many postponed procedures will hinder the pace of recovery to some extent. Nonetheless, following short-term disruption due to the global pandemic, the Asia Pacific GI endoscopy device market will grow throughout the remainder of the forecast period, primarily driven by the growth of underpenetrated endoscopy procedure volumes as more physicians become trained in endoscopic techniques.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for GI endoscopy devices in Asia Pacific across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…